$0.02 EPS Expected for Endeavour Silver (EDR); Bailard Raised Cvs Health (CVS) Stake By $304,746

July 17, 2017 - By Henry Gaston

Analysts expect Endeavour Silver Corp (TSE:EDR) to report $0.02 EPS on August, 3 before the open.They anticipate $0.01 EPS change or 100.00% from last quarter’s $0.01 EPS. T_EDR’s profit would be $2.55 million giving it 47.00 P/E if the $0.02 EPS is correct. After having $0.06 EPS previously, Endeavour Silver Corp’s analysts see -66.67% EPS growth. About 128,815 shares traded. Endeavour Silver Corp (TSE:EDR) has 0.00% since July 17, 2016 and is . It has underperformed by 16.70% the S&P500.

Bailard Inc increased Cvs Health Corp (CVS) stake by 7.83% reported in 2016Q4 SEC filing. Bailard Inc acquired 3,907 shares as Cvs Health Corp (CVS)’s stock declined 4.23%. The Bailard Inc holds 53,833 shares with $4.25M value, up from 49,926 last quarter. Cvs Health Corp now has $79.78B valuation. The stock rose 0.47% or $0.37 reaching $78.3 per share. About 2.91M shares traded. CVS Health Corp (NYSE:CVS) has declined 24.40% since July 17, 2016 and is downtrending. It has underperformed by 41.10% the S&P500.

Endeavour Silver Corp. is engaged in silver mining in Mexico, and related activities, including property acquisition, exploration, development, mineral extraction, processing, refining and reclamation. The company has market cap of $480.22 million. The Firm is engaged in exploration activities in Chile. It has a 43.94 P/E ratio. The Company’s operating mining divisions include Guanacevi, Bolanitos and El Cubo, which are located in Mexico, as well as Exploration and Corporate divisions.

Among 5 analysts covering Endeavour Silver Corp. (TSE:EDR), 2 have Buy rating, 0 Sell and 3 Hold. Therefore 40% are positive. Endeavour Silver Corp. had 23 analyst reports since July 21, 2015 according to SRatingsIntel. TD Securities downgraded Endeavour Silver Corp (TSE:EDR) on Tuesday, July 21 to “Reduce” rating. The firm has “Hold” rating given on Friday, November 4 by TD Securities. The rating was maintained by BMO Capital Markets with “Market Perform” on Wednesday, April 12. Raymond James maintained it with “Market Perform” rating and $5.50 target in Thursday, March 2 report. On Tuesday, October 25 the stock rating was maintained by Canaccord Genuity with “Hold”. The stock of Endeavour Silver Corp (TSE:EDR) earned “Sector Underperformer” rating by IBC on Tuesday, February 23. On Tuesday, April 11 the stock rating was maintained by Raymond James with “Outperform”. Raymond James maintained the shares of EDR in report on Thursday, January 26 with “Market Perform” rating. The rating was maintained by Raymond James on Monday, April 3 with “”. On Thursday, October 29 the stock rating was initiated by Ringler Research with “Outperform”.

Investors sentiment decreased to 0.74 in Q4 2016. Its down 0.24, from 0.98 in 2016Q3. It dropped, as 135 investors sold CVS shares while 627 reduced holdings. 127 funds opened positions while 440 raised stakes. 830.51 million shares or 0.72% less from 836.58 million shares in 2016Q3 were reported. Maple Mngmt Incorporated has invested 2.12% in CVS Health Corp (NYSE:CVS). 8,033 were accumulated by Sol Mngmt. New York-based Tiaa Cref Inv Management Lc has invested 0.33% in CVS Health Corp (NYSE:CVS). Wade G W And Incorporated reported 0.13% stake. Arrow Fincl holds 0.62% of its portfolio in CVS Health Corp (NYSE:CVS) for 31,820 shares. Valley National Advisers Inc invested 0.06% in CVS Health Corp (NYSE:CVS). Wellington Shields & stated it has 7,200 shares. Clal Insur Limited accumulated 20,000 shares. Selway Asset Mgmt invested in 2.45% or 51,803 shares. Winfield Assoc owns 3,785 shares for 0.18% of their portfolio. Monetary Management stated it has 2.09% in CVS Health Corp (NYSE:CVS). Huntington National Bank & Trust holds 0.62% or 435,525 shares. Private Advisor Grp Inc Limited Liability Com has invested 0.11% in CVS Health Corp (NYSE:CVS). Comerica Bank holds 0.24% or 363,013 shares. Rmb Cap Management Ltd Llc invested in 170,503 shares or 0.72% of the stock.

Bailard Inc decreased Exxon Mobil Corp (NYSE:XOM) stake by 26,759 shares to 34,843 valued at $3.15M in 2016Q4. It also reduced Ishares Tr (IYR) stake by 4,676 shares and now owns 21,180 shares. Ishares Tr (CIU) was reduced too.

Among 21 analysts covering CVS Health (NYSE:CVS), 13 have Buy rating, 0 Sell and 8 Hold. Therefore 62% are positive. CVS Health had 32 analyst reports since July 22, 2015 according to SRatingsIntel. The stock of CVS Health Corp (NYSE:CVS) has “Hold” rating given on Thursday, August 20 by Deutsche Bank. The stock has “Neutral” rating by Atlantic Securities on Monday, February 6. On Monday, November 2 the stock rating was maintained by JP Morgan with “Overweight”. The stock has “Neutral” rating by Goldman Sachs on Thursday, December 17. The company was maintained on Monday, August 10 by Argus Research. The rating was downgraded by Jefferies on Monday, December 12 to “Hold”. Jefferies maintained the stock with “Buy” rating in Thursday, May 12 report. The company was initiated on Friday, January 22 by Robert W. Baird. Mizuho maintained the stock with “Buy” rating in Thursday, June 23 report. Robert W. Baird downgraded it to “Neutral” rating and $77 target in Thursday, February 2 report.

Since February 1, 2017, it had 0 insider buys, and 7 selling transactions for $40.53 million activity. Boratto Eva C sold $479,908 worth of stock or 6,029 shares. 23,849 CVS Health Corp (NYSE:CVS) shares with value of $1.88M were sold by Brennan Troyen A. 95,618 CVS Health Corp (NYSE:CVS) shares with value of $7.71 million were sold by Denton David M. On Monday, March 13 the insider Sussman Andrew sold $1.13 million. MERLO LARRY J had sold 76,494 shares worth $5.99 million. Roberts Jonathan C sold $4.90M worth of stock or 61,196 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.